Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution.

AIM To investigate the efficacy of rebamipide in a rat model of colitis and restitution of intestinal epithelial cells in vitro. METHODS Acute colitis was induced with trinitrobenzene sulfonic acid (TNBS) in male Wistar rats. Rats received intrarectal rebamipide treatment daily starting on day 7 and were sacrificed on day 14 after TNBS administration. The distal colon was removed to evaluate the various parameters of inflammation. Moreover, wound healing assays were used to determine the enhanced restitution of rat intestinal epithelial (RIE) cells treated with rebamipide. RESULTS Intracolonic administration of rebamipide accelerated TNBS-induced ulcer healing. Increases in the wet weight of the colon after TNBS administration were significantly inhibited by rebamipide. The wound assay revealed that rebamipide enhanced the migration of RIE cells through phosphorylation of extracellular signal-regulated kinase (ERK) and activation of Rho kinase. CONCLUSION Rebamipide enema healed intestinal injury by enhancing restitution of RIE cells, via ERK activation. Rebamipide might be a novel therapeutic approach for inflammatory bowel disease.

[1]  Y. Naito,et al.  Ecabet sodium promotes the healing of trinitrobenzene‐sulfonic‐acid‐induced ulceration by enhanced restitution of intestinal epithelial cells , 2010, Journal of gastroenterology and hepatology.

[2]  Y. Naito,et al.  Rebamipide: a gastrointestinal protective drug with pleiotropic activities , 2010, Expert review of gastroenterology & hepatology.

[3]  I. Skrypnyk.  Diagnostic and Treatment Algorithms of Ulcerative Colitis in Ukraine , 2009, Digestive Diseases.

[4]  S. Shirahama,et al.  Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: open label study. , 2008, World journal of gastroenterology.

[5]  M. Blumenberg,et al.  Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratinocytes , 2008, Journal of cellular physiology.

[6]  M. Nishizawa,et al.  Rebamipide, anti-gastric ulcer drug, up-regulates the induction of iNOS in proinflammatory cytokine-stimulated hepatocytes. , 2008, Nitric oxide : biology and chemistry.

[7]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[8]  A. Kurimasa,et al.  Effect of rectal administration of rebamipide on dextran sulfate sodium-induced colitis: Role of hepatocyte growth factor , 2007, Inflammation Research.

[9]  J. Capó-Aponte,et al.  Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. , 2006, Investigative ophthalmology & visual science.

[10]  D. Dartt,et al.  OPC-12759 Increases Proliferation of Cultured Rat Conjunctival Goblet Cells , 2006, Cornea.

[11]  H. Matsui,et al.  Direct Autoradiographic Evidence that Rebamipide Interacts with Neutrophils in Dextran Sulfate Sodium Induced Colitis in Rats , 2005, Digestive Diseases and Sciences.

[12]  Toyoki Mori,et al.  Rebamipide Enema is Effective for Treatment of Experimental Dextran Sulfate Sodium Induced Colitis in Rats , 2005, Digestive Diseases and Sciences.

[13]  T. Ishikawa,et al.  Rebamipide Enemas–New Effective Treatment for Patients with Corticosteroid Dependent or Resistant Ulcerative Colitis , 2005, Digestive Diseases and Sciences.

[14]  K. Takeuchi,et al.  Protective Effect of Intra-Rectal Administration of Rebamipide on Dextran Sulfate Sodium-Induced Rat Colitis , 2005, Digestion.

[15]  H. Shinohara,et al.  Rebamipide Increases the Amount of Mucin-like Substances on the Conjunctiva and Cornea in the N-Acetylcysteine-Treated In Vivo Model , 2004, Cornea.

[16]  H. Ford,et al.  Endotoxin Inhibits Intestinal Epithelial Restitution through Activation of Rho-GTPase and Increased Focal Adhesions* , 2004, Journal of Biological Chemistry.

[17]  Daniel K. Podolsky,et al.  Trefoil factors: initiators of mucosal healing , 2003, Nature Reviews Molecular Cell Biology.

[18]  K. Takagi,et al.  Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipide , 2003, Alimentary pharmacology & therapeutics.

[19]  M. Tanito,et al.  Cytoprotective effects of rebamipide and carteolol hydrochloride against ultraviolet B-induced corneal damage in mice. , 2003, Investigative ophthalmology & visual science.

[20]  J. Yuan,et al.  Polyamines regulate Rho-kinase and myosin phosphorylation during intestinal epithelial restitution. , 2003, American journal of physiology. Cell physiology.

[21]  Van Deventer,et al.  Small therapeutic molecules for the treatment of inflammatory bowel disease , 2002, Gut.

[22]  Ji Young Kim,et al.  The Inhibitory Mechanism of Rebamipide on the Mediator Release in the Guinea Pig Lung Mast Cells Activated with Specific Antigen-Antibody Reactions , 2001, Pharmacology.

[23]  Shinya Kishimoto,et al.  Rebamipide, an Antiulcer Drug, Prevents DSS-Induced Colitis Formation in Rats , 2000, Digestive Diseases and Sciences.

[24]  T. A. Najjar,et al.  The effect of rebamipide on cisplatin-induced nephrotoxicity in rats. , 2000, Pharmacological research.

[25]  S. Narumiya,et al.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. , 2000, Molecular pharmacology.

[26]  J. Thiery,et al.  Phosphorylation of Tyrosine Residues 31 and 118 on Paxillin Regulates Cell Migration through an Association with Crk in Nbt-II Cells , 2000, The Journal of cell biology.

[27]  I. Rabinovitz,et al.  Intestinal restitution: progression of actin cytoskeleton rearrangements and integrin function in a model of epithelial wound healing. , 2000, The American journal of pathology.

[28]  R. Playford,et al.  Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy? , 2000, Gut.

[29]  D. Podolsky,et al.  V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[30]  W. S. Lee,et al.  Effect of rebamipide on liver damage and increased tumor necrosis factor in a rat model of endotoxin shock. , 1998, Digestive diseases and sciences.

[31]  K. Sakurai,et al.  Protection by rebamipide against acetic acid-induced colitis in rats: relationship with its antioxidative activity. , 1998, Digestive diseases and sciences.

[32]  A. Iwai,et al.  Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamipide. , 1998, Digestive diseases and sciences.

[33]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[34]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[35]  S. Yamamoto,et al.  Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis , 1997, Gut.

[36]  Y. Zheng,et al.  Rho proteins play a critical role in cell migration during the early phase of mucosal restitution. , 1997, The Journal of clinical investigation.

[37]  S. Lee,et al.  Rebamipide ameliorates hepatic dysfunction induced by ischemia/reperfusion in rats. , 1995, European journal of pharmacology.

[38]  J. Wallace,et al.  Disruption of colonic electrolyte transport in experimental colitis. , 1995, The American journal of physiology.

[39]  J. Wallace,et al.  Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.

[40]  A. Tarnawski,et al.  Rebamipide Inhibits Gastric Cancer Cell Growth , 2006, Digestive Diseases and Sciences.

[41]  PhD K. Makiyama MD,et al.  Efficacy of Rebamipide Enemas in Active Distal Ulcerative Colitis and Proctitis: A Prospective Study Report , 2005, Digestive Diseases and Sciences.

[42]  R. Okamoto,et al.  Cellular and Molecular Mechanisms of the Epithelial Repair in IBD , 2005, Digestive Diseases and Sciences.

[43]  S. Ohno,et al.  Efficacy of Rebamipide as Adjunctive Therapy in the Treatment of Recurrent Oral Aphthous Ulcers in Patients with Behçet’s Disease , 2003, Drugs in R&D.

[44]  F. Takeshima,et al.  Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative , 2000, American Journal of Gastroenterology.

[45]  C. Fiocchi.  Mucosal immunity and inflammation , 1989 .